Hello, everyone. This is Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the third quarter 2026 results and strategy ...
More than $500 billion in branded drug sales could face generic competition from 2026 to 2032, while a new report says the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results